...
首页> 外文期刊>American Journal of Pathology >Interleukin-11 in Endometrial Adenocarcinoma Is Regulated by Prostaglandin F2{alpha}-F-Prostanoid Receptor Interaction via the Calcium-Calcineurin-Nuclear Factor of Activated T Cells Pathway and Negatively Regulated by the Regulator of Calcineurin-1
【24h】

Interleukin-11 in Endometrial Adenocarcinoma Is Regulated by Prostaglandin F2{alpha}-F-Prostanoid Receptor Interaction via the Calcium-Calcineurin-Nuclear Factor of Activated T Cells Pathway and Negatively Regulated by the Regulator of Calcineurin-1

机译:子宫内膜腺癌中的白细胞介素11受前列腺素F2 {α} -F-前列腺素受体相互作用的激活T细胞途径的钙-钙调磷酸酶-核因子的调节,并由钙调磷酸酶-1的调节剂负调节。

获取原文
获取原文并翻译 | 示例
           

摘要

Interleukin-11 (IL-11) up-regulates the proliferative and invasive capacity of many cancers. Coexpression of glycoprotein 130 (GP130) and IL-11 receptor (IL-11R) is necessary for high-affinity binding of IL-11 to IL-11R. This study investigated the expression of IL-11 and role of prostaglandin F2-F-prostanoid receptor (FP receptor) signaling in the modulation of IL-11 expression in endometrial adenocarcinoma cells. Localization of IL-11, IL-11R, and GP130 expression was performed by immunohistochemistry. IL-11 and regulator of calcineurin 1 isoform 4 (RCAN1-4) mRNA and protein expression were determined by real-time RT-PCR and/or enzyme-linked immunosorbent assay/Western blot analysis using Ishikawa endometrial adenocarcinoma cells stably expressing the FP receptor (FPS cells) and endometrial adenocarcinoma explants. IL-11 mRNA expression was significantly elevated in endometrial adenocarcinoma samples compared with normal endometrium and increased with tumor grade. IL-11 protein expression localized with FP receptor, IL-11R, and GP130 in the neoplastic glandular epithelium of endometrial adenocarcinomas. Prostaglandin F2-FP receptor signaling significantly elevated the expression of IL-11 mRNA and protein in a Gq-protein kinase C-calcium-calcineurin-nuclear factor of activated T cells-dependent manner in FPS cells. The calcineurin signaling pathway is known to be controlled by the RCAN (RCAN1-4). Indeed, RCAN1-4 expression was significantly elevated in well-differentiated endometrial adenocarcinoma compared with normal endometrium and was found to decrease with tumor grade and negatively regulate IL-11 expression in vitro. This study has highlighted a new mechanism regulating IL-11 expression in endometrial adenocarcinoma cells by the FP receptor via the calcium-calcineurin-nuclear factor of activated T cells pathway.
机译:白细胞介素11(IL-11)上调许多癌症的增殖能力和侵袭性 能力。糖蛋白130(GP130) 和IL-11受体(IL-11R)的共表达对于IL-11与IL-11R的高亲和力结合是必需的。这项研究调查了IL-11的表达和前列腺素F 2 -F-前列腺素受体 (FP受体)在调节HLA中的作用。 IL-11在子宫内膜腺癌细胞中的表达 。 IL-11, IL-11R和GP130的表达通过免疫组织化学进行定位。 IL-11和钙调神经磷酸酶1亚型4(RCAN1-4)mRNA的调节剂酶联免疫吸附测定/ Western blot分析,使用 Ishikawa子宫内膜腺癌细胞稳定表达 FP受体(FPS细胞)和子宫内膜腺癌外植体。与正常子宫内膜和正常子宫内膜相比,子宫内膜 腺癌样品中IL-11 mRNA表达显着升高。 随着肿瘤等级的增加而增加。 IL-11蛋白表达在子宫内膜腺癌的肿瘤腺上皮中定位为FP受体,IL-11R和GP130。前列腺素F 2 -FP 受体信号显着提高Gq蛋白激酶C-钙调神经磷酸酶中 IL-11 mRNA和蛋白的表达FPS细胞中活化T细胞依赖方式的-nuclear 因子。已知 calcineurin信号传导途径受 RCAN(RCAN1-4)控制。确实,与正常子宫内膜相比,在分化良好的子宫内膜腺癌中RCAN1-4表达显着升高,并随肿瘤分级而降低。在体外调节IL-11表达。这项研究突显了一种新的机制,即FP受体通过 钙-钙调神经磷酸酶核因子,调节子宫内膜腺癌细胞中IL-11表达 。激活的T细胞途径。

著录项

  • 来源
    《American Journal of Pathology》 |2010年第1期|435-445|共11页
  • 作者单位

    From the Medical Research Council Human Reproductive Sciences Unit,The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom;

    From the Medical Research Council Human Reproductive Sciences Unit,The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom;

    From the Medical Research Council Human Reproductive Sciences Unit,The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom;

    From the Medical Research Council Human Reproductive Sciences Unit,The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom|and the Departments of Reproductive and Developmental Sciences,The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom;

    and the Departments of Reproductive and Developmental Sciences,The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom;

    and Pathology,The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom;

    From the Medical Research Council Human Reproductive Sciences Unit,The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号